These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21526190)

  • 1. Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis.
    Altomare DA; Menges CW; Xu J; Pei J; Zhang L; Tadevosyan A; Neumann-Domer E; Liu Z; Carbone M; Chudoba I; Klein-Szanto AJ; Testa JR
    PLoS One; 2011 Apr; 6(4):e18828. PubMed ID: 21526190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice.
    Altomare DA; Menges CW; Pei J; Zhang L; Skele-Stump KL; Carbone M; Kane AB; Testa JR
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3420-5. PubMed ID: 19223589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf).
    Chernova T; Murphy FA; Galavotti S; Sun XM; Powley IR; Grosso S; Schinwald A; Zacarias-Cabeza J; Dudek KM; Dinsdale D; Le Quesne J; Bennett J; Nakas A; Greaves P; Poland CA; Donaldson K; Bushell M; Willis AE; MacFarlane M
    Curr Biol; 2017 Nov; 27(21):3302-3314.e6. PubMed ID: 29112861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.
    Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT
    Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
    Bardeesy N; Aguirre AJ; Chu GC; Cheng KH; Lopez LV; Hezel AF; Feng B; Brennan C; Weissleder R; Mahmood U; Hanahan D; Redston MS; Chin L; Depinho RA
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5947-52. PubMed ID: 16585505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
    Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
    Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
    Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM
    Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model recapitulating molecular features of human mesothelioma.
    Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR
    Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
    Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
    Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma.
    Lecomte C; Andujar P; Renier A; Kheuang L; Abramowski V; Mellottee L; Fleury-Feith J; Zucman-Rossi J; Giovannini M; Jaurand MC
    Cell Cycle; 2005 Dec; 4(12):1862-9. PubMed ID: 16319530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
    Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
    Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.